Form D · Biotechnology
Ordaos, Inc.
New York, NY · CIK 0001933700
Offering snapshot reported Apr 1, 2025 · SEC filing
- Reported sold
- $338K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Feb 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2025 | Initial | $337,705 | No comparison | 3 | SEC filing |
| Sep 11, 2024 | Initial | $3,104,999 | No comparison | 5 | SEC filing |
| Dec 29, 2023 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Dec 28, 2023 | Initial | $332,000 | No comparison | 4 | SEC filing |
| Nov 3, 2023 | Initial | $1,800,000 | No comparison | 4 | SEC filing |
| Jun 15, 2022 | Initial | $10,742,419 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-542680
Source: Form D, filed Apr 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Britt | Director |
| Scott Horner | Director |
| David Longo | Director, Executive |
| Ulo Palm | Director |
| James Ramey | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
228 Park Avenue S #60684
New York, NY, 10003
New York, NY, 10003